SMI
13.136,27
PKT
+104,37
PKT
+0,80
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu SMI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 12.11.12 | UBS outperform | Macquarie Research | |
| 09.11.12 | Swiss Re kaufen | Norddeutsche Landesbank (Nord/LB) | |
| 09.11.12 | Swiss Re buy | UBS AG | |
| 09.11.12 | Swisscom outperform | Exane-BNP Paribas SA | |
| 09.11.12 | Zurich Insurance neutral | Exane-BNP Paribas SA | |
| 09.11.12 | Swiss Re buy | Société Générale Group S.A. (SG) | |
| 09.11.12 | Swiss Re neutral | Exane-BNP Paribas SA | |
| 09.11.12 | Swiss Re reduce | Nomura | |
| 09.11.12 | UBS outperform | Cheuvreux SA | |
| 09.11.12 | Swisscom neutral | Sarasin Research | |
| 09.11.12 | Richemont neutral | Sarasin Research | |
| 09.11.12 | Swisscom hold | Vontobel Research | |
| 09.11.12 | Swiss Re buy | Vontobel Research | |
| 09.11.12 | Richemont buy | Vontobel Research | |
| 08.11.12 | UBS overweight | HSBC | |
| 08.11.12 | UBS neutral | HSBC | |
| 08.11.12 | Holcim outperform | Exane-BNP Paribas SA | |
| 08.11.12 | Swisscom hold | Vontobel Research | |
| 08.11.12 | Novartis reduce | Vontobel Research | |
| 08.11.12 | Swiss Re buy | Vontobel Research | |
| 08.11.12 | Swiss Re neutral | Sarasin Research | |
| 08.11.12 | Holcim hold | Vontobel Research | |
| 08.11.12 | Novartis outperform | Sanford C. Bernstein and Co., Inc. | |
| 07.11.12 | UBS halten | Hamburger Sparkasse AG (Haspa) | |
| 07.11.12 | Novartis reduce | Vontobel Research | |
| 07.11.12 | Holcim neutral | Sarasin Research | |
| 07.11.12 | Holcim hold | Vontobel Research | |
| 07.11.12 | UBS buy | Vontobel Research | |
| 06.11.12 | Swisscom outperform | Exane-BNP Paribas SA | |
| 06.11.12 | Novartis neutral | J.P. Morgan Cazenove | |
| 06.11.12 | Holcim hold | Société Générale Group S.A. (SG) | |
| 06.11.12 | Partners Group buy | Sarasin Research | |
| 05.11.12 | Swiss Re sell | Goldman Sachs Group Inc. | |
| 05.11.12 | Novartis neutral | Citigroup Corp. | |
| 05.11.12 | Holcim buy | Société Générale Group S.A. (SG) | |
| 05.11.12 | Partners Group hold | Vontobel Research | |
| 05.11.12 | Partners Group neutral | Sarasin Research | |
| 05.11.12 | UBS buy | Citigroup Corp. | |
| 06.11.12 | Novartis outperform | Exane-BNP Paribas SA | |
| 02.11.12 | Swiss Re buy | Société Générale Group S.A. (SG) |
* Die angezeigten Realtime Kurse sind indikativ und nicht die offiziellen Börsenkurse. Die Kursdaten können eventuell vom tatsächlichen Marktpreis abweichen.